EU Approves Oral Weight-Loss Pill Foundayo, Rival to Injectable GLP-1s
Published 14 h ago1 sourceEvidence: Unknown
Hypera, a Brazilian pharmaceutical company, reports that sales of its slimming pen have doubled since its launch in early September. The product's rapid uptake suggests strong demand in the weight-loss market, potentially impacting Hypera's revenue outlook. The sustainability of this growth and competitive dynamics remain uncertain.
AI disclosure: Model-written summary of the source, not a verified fact. Check the sources. How Mosaic works
Published 14 h ago1 sourceEvidence: Unknown
Published 21 h ago9 sourcesEvidence: Reported
Published 2 d ago15 sourcesEvidence: Unknown
Published 2 d ago12 sourcesEvidence: Reported
Published 2 d ago7 sourcesEvidence: Reported
Published 1 d ago6 sourcesEvidence: Reported
Published 1 d ago12 sourcesEvidence: Reported
Published 1 d ago15 sourcesEvidence: Reported